Guanylate Cyclase
- Name
- Guanylate Cyclase
- Accession Number
- DBCAT002760
- Description
Not Available
- Drugs
Drug Drug Description Riociguat A stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. Cinaciguat Cinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ΜG/h, 10 ΜG/h) Given Intravenously to Patients... - Drugs & Drug Targets
Drug Target Type Riociguat Serum albumin carrier Riociguat Alpha-1-acid glycoprotein 1 carrier Riociguat Guanylate cyclase soluble subunit alpha-2 target Riociguat ATP-binding cassette sub-family G member 2 transporter Riociguat Cytochrome P450 1A1 enzyme Riociguat Cytochrome P450 3A4 enzyme Riociguat Cytochrome P450 2C8 enzyme Riociguat Cytochrome P450 2J2 enzyme Riociguat P-glycoprotein 1 transporter